Darkfield imaging relies on differences in the scatter component of the x-ray distribution due to differences instructural conditions oft he tissue. In many approaches this component is a side-product of phase contrast imaging. Since phase contrast imaging is strongly dependent on movements oft he patient and it will be dose intensive for applications in the human tissue characterisation for in vivo imaging, we are concentrating on darkfield X-ray imaging directly. A special system for dose-optimised imaging will be developed. We focus on breast imaging within the current project.